Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alternate Health Club vs FMmeds

Alternate Health Club
Graded #111

Higher grade

vs+6.599999999999994
FMmeds
Graded #257

Lower grade

The verdict

Alternate Health Club takes it — 69.8/100 to 63.2/100.

Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlternate Health Club +38
84
46
Dose & formulationFMmeds +8
64
72
Clinical oversightAlternate Health Club +7
77
70
Labs & monitoringFMmeds +1
52
53
FulfillmentFMmeds +27
70
97
Contract termsAlternate Health Club +8
55
47
Alternate Health Club · left barFMmeds · right bar

The numbers

MetricAlternate Health ClubFMmeds
WeighScore69.8/10063.2/100
GradeCC
Scorecard rank#111#257
Semaglutide$129/mo (compounded)$225/mo (all doses, compounded)
Tirzepatide$169/mo (compounded)$265/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Alternate Health Club

Graded #111 · C

Strengths

  • $129/month compounded semaglutide is among the cheapest in the US market
  • $169/month compounded tirzepatide is competitive with established platforms
  • Complimentary workout and dietary plans bundled with medication — most peers don't
  • LegitScript verified
  • US-licensed clinicians

Where it loses points

  • Parent company / legal entity not publicly disclosed
  • State of incorporation not disclosed
  • Per-state availability not listed — confirm your state ships before committing
  • Pharmacy partners not publicly named
  • Unclear whether lab work is included
FMmeds

Graded #257 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard